These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23678072)

  • 21. The impact of an electronic medical record nudge on reducing testing for hospital-onset
    Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of an electronic smart order-set for diagnostic stewardship of Clostridiodes difficile infection (CDI) in a community healthcare system in South Florida.
    Eckardt P; Guran R; Jalal AT; Krishnaswamy S; Samuels S; Canavan K; Martinez EA; Desai A; Miller N; Cano Cevallos EJ
    Am J Infect Control; 2024 Aug; 52(8):893-899. PubMed ID: 38935020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?
    Barbut F; Surgers L; Eckert C; Visseaux B; Cuingnet M; Mesquita C; Pradier N; Thiriez A; Ait-Ammar N; Aifaoui A; Grandsire E; Lalande V
    Clin Microbiol Infect; 2014 Feb; 20(2):136-44. PubMed ID: 23565919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile infection in fever patients with gynecological malignancies.
    Yanazume S; Tokudome A; Fukuda M; Togami S; Kamio M; Ota S; Kobayashi H
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1200. PubMed ID: 32721136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hospitals.
    Zacharioudakis IM; Zervou FN; Phillips MS; Aguero-Rosenfeld ME
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115346. PubMed ID: 33647544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden and risk factors for inappropriate Clostridioides Difficile infection testing among hospitalized patients.
    Axenfeld E; Greendyke WG; Li J; Green DA; Whittier S; Freedberg DE
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115283. PubMed ID: 33360514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.
    Dubberke ER; Han Z; Bobo L; Hink T; Lawrence B; Copper S; Hoppe-Bauer J; Burnham CA; Dunne WM
    J Clin Microbiol; 2011 Aug; 49(8):2887-93. PubMed ID: 21697328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile infection mimics intestinal acute cellular rejection in pediatric multivisceral transplant-A case series.
    Cheung DA; Beduschi T; Tekin A; Selvaggi G; Ruiz P; Vianna RM; Garcia J
    Pediatr Transplant; 2020 Feb; 24(1):e13621. PubMed ID: 31815352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.
    Deshpande A; Pasupuleti V; Patel P; Ajani G; Hall G; Hu B; Jain A; Rolston DD
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):665-669.e1. PubMed ID: 21635969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.
    Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ;
    Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical factors associated with development of severe-complicated Clostridium difficile infection.
    Shivashankar R; Khanna S; Kammer PP; Harmsen WS; Zinsmeister AR; Baddour LM; Pardi DS
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1466-71. PubMed ID: 23702192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

  • 36. A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.
    Han Z; McMullen KM; Russo AJ; Copper SM; Warren DK; Dubberke ER
    Am J Infect Control; 2012 May; 40(4):349-53. PubMed ID: 21794950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes.
    Willis DN; Huang FS; Elward AM; Wu N; Magnusen B; Dubberke ER; Hayashi RJ
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):302-308. PubMed ID: 32766672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.
    Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW
    Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.